Asahi Kasei has established the “Care for Earth” investment facility as a new initiative to achieve carbon neutrality. The company will invest $100 million globally over a five-year period through fiscal 2027 in early-stage startup companies that are working to solve problems in environmental fields such as hydrogen, energy storage, carbon management, and bio-chemicals. Since 2008, the company has been...
The Japanese Rubber Workers Union Confederation (JRC), an organization of labor unions of rubber manufacturers, recently announced the results of wage and lump-sum payment settlements at major rubber companies for the spring of 2023. According to the report, 35 out of the 47 unions (75%) that submitted written demands have reached wage agreements. Of the 32 unions that were able...
Lanxess participated at the Tire Technology Expo 2023 in Hannover, Germany, from March 21 to 23, and presented new product solutions for sustainable tire production developed by its Rhein Chemie business unit. The products introduced include Vulkanox HS, an anti-aging agent made from more than 50% sustainable raw materials, and Aktiplast 79, a silicone-free mold release agent and rubber processing...
Zeon’s Tokuyama Plant in Shunan City, Yamaguchi Prefecture, participated in the Blue Carbon Offset Credit System utilizing J Blue Credits certified and issued by the Japan Blue Economy Association (JBE). In recent years, blue carbon has been attracting attention as a CO2 sink, and efforts to preserve and restore blue carbon ecosystems are underway in many areas. One such example...
Bando subsidiary Aimedic MMT has launched on April 1 an absorbable bone regeneration material marketed as e=Bone. The material uses the results of a research project for the development of artificial bones in industry-academia collaboration with the Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, and the Department of Materials Production Science, Osaka University Graduate School of Engineering....
Sumitomo Riko, in collaboration with Ginreilab, has completed a Microphysiological Systems (MPS) prototype, which can be used to confirm the efficacy and evaluate the safety of pharmaceuticals and other products, the company revealed at the 22nd Annual Meeting of the Japanese Society for Regenerative Medicine. In recent years, the global trend has been to verify the efficacy and safety of...
Signup today for free.
You will receive a weekly or daily roundup on what has been published and will be up to date on special offers.
Please make sure to select your preferred sending frequency!
Note: We save your entered data to send the newsletter. You can always easily unsubscribe. More information on data handling: Privacy Policy.
Close window
